Sexually transmitted human papillomaviruses: Current concepts and control issues

Canadian Journal of Human Sexuality

Volumn 6, Issue 2, 1997, Pages 113-126

  Lytwyn, Alice ^a   Sellors, John W ^b  

^a WOMEN S COLLEGE HOSPITAL   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Cervical cancer; HPV control strategies; HPV testing; HPV treatment; Human papillomavirus

Indexed keywords

CANADA; CONFERENCE PAPER; DISEASE COURSE; DISEASE PREDISPOSITION; HUMAN; IMMUNE STATUS; INCIDENCE; INFECTION PREVENTION; MONITORING; MOTIVATION; PREVALENCE; SEXUALLY TRANSMITTED DISEASE; VACCINATION; VIRUS PARTICLE; WART VIRUS;

EID: 0030789423     PISSN: 11884517     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (112)

1. American Social Health Association. (1993). Survey shows how we live with HPV. HPV News, 3, 1.
2. Apple, R.J., Erlich, H.A., Klitz, W., Manos, M.M., Becker, T.M., & Wheeler, C.M. (1994). HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity.Nature Genetics, 6, 157-162.
3. Arenas, M.J., Benton, E.C., McLaren, K.M., Stark, L.A., Hunter, J.A.A., & Bird, C.C. (1997). Renal-allograft recipients with high susceptibility to cutaneous malignancy have an increased prevalence of human papillomavirus DNA in skin tumors and a greater risk of anogenital malignancy. British Journal of Cancer, 75, 722-728.
4. Bauer, H.M., Yi Ting, M.S., Greer, C.E., Chambers, J.C., Tashiro, C.J., Chimera, J., Reingold, A., & Manos, M. (1991). Genitalhuman papillomavirus infection in female university students as determined by a PCR-based method. Journal of the American Medical Association, 265, 472-477.
5. Bavin, P.J., Giles, J.A., & Deery, A. (1993). Use of semiquantitative PCR for human papillomavirus DNA type 16 to identify women with high grade cervical disease in a population presenting with a mildly dyskaryotic smear report. British Journal of Cancer, 67, 602-605.
6. Bavin, P.J., Giles, J.A., Hudson, E., Williams, D., Crow, J., Griffiths, P.D., Emery, V.C., & Walker, P.G. (1992). Comparison of cervical cytology and the polymerase chain reaction for HPV 16 to identify women with cervical disease in a general practice population. Journal of Medical Virology, 37, 8-12.
7. Birley, H.D.L., Hart, C.A., & Stacey, S.N. (1995). Human papillomaviruses and the genital tract: Old virus, new developments. Journal of Medical Microbiology, 43, 81-84.
8. Bishop, A., Sherris, J., & Tsu, V.D. (1995). Cervical dysplasia treatment in developing countries: A situation analysis. Washington, DC: The World Bank, Program for Appropriate Technology in Health.
9. Borysiewicz, L.K., Flander, A., Nimako, M., Man, S., Wilkinson, G.W.G., Westmoreland, D., Evans, A.S., Adams, M., Stacey, S.N., Boursnell, M.E.G., Rutherford, E., Hickling, J.K., & Inglis, S.C. (1996). A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer. Lancet, 347, 1523-1527.
10. Bosch, F.X., Manos, M.M., Munoz, N., Sherman, M., Jansen, A.M., Peto, J., Schiffman, M.H., Moreno, V., Kurman, R., & Shah, K.V. (1995). Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. Journal of the National Cancer Institute, 87, 796-802.
11. Brisson, J., Bairati, I., Morin, C., Fortier, M., Bouchard, C., Christen, A., Bernard, P., Roy, M., & Meisels, A. (1996). Determinants of persistent detection of human papillomavirus DNA in the uterine cervix. Journal of Infectious Diseases, 173, 794-799.
12. Brotzman, G.L., & Julian, T.M. (1996). The minimally abnormal Papanicolaou smear. American Family Physician, 53, 1154-1162.
13. Brownstein, J.N., Cheal, N., Achermann, S.P., Bassford, T.L., & Campos-Outcalt, D. (1992). Breast and cervical cancer screening in minority populations: A model for using lay health educators.Journal of Cancer Education, 7, 321-326.
14. Campion, M.J., McCance, D.J., Cuzick, J., & Singer, A. (1986). Progressive potential of mild cervical atypia: Prospective, cytological, colposcopic and virological study. Lancet, 2, 237-240.
15. Carlson, J.W., & Twiggs, L.B. (1992). Clinical applications of molecular biologic screening for human papillomavirus: Diagnostic techniques. Clinical Obstetrics and Gynecology, 35, 13-21.
16. Cason J. (1996). Perinatal acquisition of cervical cancer-associated papillomaviruses. British Journal of Obstetrics and Gynaecology, 103, 853-858.
17. Castro, K.G., Ward, J.W., Slutsker, L., Buehler, J.W., Jaffe, H.W., Berkelman, R.L., & Curran, J.W. (1992). 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morbidity and Mortality Weekly Report, 41, 1-19.
18. Corbitt, G., Zarod, A.P., Arrand, J.R., Longson, M., & Farrington, W.Y. (1988). Human papillomavirus (HPV) genotypes associated with laryngeal papilloma.Journal of Clinical Pathology, 41, 284-288.
19. Coutlee, F., Hankins, C., Lapointe, N. & the Canadian Women's HIV Study Group. (1997). Comparison between vaginal tampon and cervicovaginal lavage specimen collection for detection of human papillomavirus DNA by the polymerase chain reaction. Journal of Medical Virology, 51, 42-47.
20. Cox, J.T., Lorincz, A.T., Schiffman, M.H., Sherman, M.E., Cullen, A., & Kurman, R.J. (1995). Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of unknown significance. American Journal of Obstetrics and Gynecology, 172, 946-954.
21. Cox, J.T., Schiffman, M.H., Winzelberg, A.J., & Patterson, M.S. (1992). An evaluation of human papillomavirus testing as part of referral to colposcopy clinics. Obstetrics and Gynecology, 80, 389-395.
22. Coyne, C.A., Hohman, K., & Levinson, A. (1992). Reaching special populations with breast and cervical cancer public education. Journal of Cancer Education, 7, 293-303.
23. Cruickshank, M.E., & Kitchener, H.C. (1996). The problem with low-grade Pap smears. Contemporary Ob/Gyn, 41, 80-93.
24. Cuzick, J., Szarewski, A., Terry, G., Ho, L., Hanby, A., Maddox, P., Anderson, M., Kocjan, G., Steele, S.T., & Guillebaud, J. (1995). Human papillomavirus testing in primary cervical screening. Lancet, 345, 1533-1536.
25. Derkay, C.S. (1995). Task force on recurrent respiratory papillomas. A preliminary report. Archives of Otolaryngology Head and Neck Surgery, 121, 1386-1391.
26. De Villiers, E-M., Wagner, D., Schneider, A., Wesch, H., Nunz, F., Miklaw, H., & zur Hausen, H. (1992). Human papillomavirus DNA in women without and with cytological abnormalities: Results of a 5-year follow-up study. Gynecologic Oncology, 44, 33-39.
27. Ellen, J.M., Moscicki, A.B., & Shafer, M.A.B. (1994). Genital herpes simplex virus and human papillomavirus infection.Advances in Pediatric Infectious Diseases, 9, 97-124.
28. Euvrard, S., Kanitakis, J., Chardonnet, Y., Noble, C.P., Touraine, J.L., Faure, M., Thivolet, J., & Claudy, A. (1997). External anogenital lesions in organ transplant recipients: A clinicopathological and virological assessment Archives of Dermatology, 133, 175-178.
29. Fairley, C.K., Chen, S., Tabrizi,S.N., Quinn, M.A., McNeil, J.J., & Garland, S.M. (1992). Tampons: A novel patient-administered method for the assessment of genital human papillomavirus infection. Journal of Infectious Diseases, 165, 1103-1106.
30. Ferenczy, A. (1994). Cervical screening. Contemporary Ob/Gyn, 39, 10-18.
31. Ferenczy, A. (1995a). Epidemiology and clinical pathophysiology of condylomata acuminata. American Journal of Obstetrics and Gynecology, 172, 1331-1339.
32. Ferenczy, A. (1995b). Viral testing for genital human papillomavirus infections: Recent progress and clinical potentials. International Journal of Gynecological Cancer, 5, 321-328.
33. Ferenczy, A., Choudroun, D., & Arseneau, J. (1996). Loop electrosurgical excision procedure for squamous intraepithelial lesions of the cervix: Advantages and potential pitfalls. Obstetrics and Gynecology, 87, 332-337.
34. Ferenczy, A., Mitao, M., Nagai, N., Silverstein, S.J., & Crum, C.P. (1985). Latent papillomavirus and recurring genital warts. New England Journal of Medicine, 313, 748-748.
35. Franco, E.L. (1994). Meeting report: 13th International Papillomavirus Conference. Papillomavirus Report, 5, 183-187.
36. Franco, E.L. (1995). Cancer causes revisited: Human papillomavirus and cervical neoplasia. Journal of the National Cancer Institute, 87, 779-780.
37. Frazer, I.H. (1996, May). Vaccines to prevent and treat human papillomavirus infection. Presented at the meeting of the Ninth World Congress on Cervical Pathology and Colposcopy; Sydney, Australia.
38. Galloway, D.A. (1994). Papillomavirus capsids: A new approach to identify serological markers of HPV infection. Journal of the National Cancer Institute, 86, 474-475.
39. Gross, G., von Krogh, G. & Barrasso, R. (1997). Genitoanal lesions. In Gerd Gross & Geo von Krough (Eds.),Human Papillomavirus in Dermatovenereology (pp. 389-410). New York: CRC Press.
40. Hankins, C.A., Lamont, J.A., & Handley, M.A. (1994). Cervicovaginal screening in women with HIV infection: A need for increased vigilance? Canadian Medical Association Journal, 150, 681-686.
41. Hankins, C.A., & Lapointe, N. (1996). The Canadian Women's HIV Study (Grant No. 6605-4164-AIDS). Ottawa: Medical Research Council of Canada.
42. Hartley, C., Hamilton, J., Birzgalis, A.R., & Farrington, W.T. (1994). Recurrent respiratory papillomatosis - the Manchester experience, 1974-1992. Journal of Laryngology and Otology, 108, 226-229.
43. Heaton, C.L. (1995). Clinical manifestations and modern management of condylomata acuminata: A dermatologic perspective. American Journal of Obstetrics and Gynecology, 172, 1344-1350.
44. Herrington, C.S. (1995). Human papillomaviruses and cervical neoplasia. II. Interaction of HPV with other factors. Journal of Clinical Pathology, 48, 1-6.
45. Herrington, C.S., Evans, M.F., Hallam, N.F., Charnock, F.M., Gray, W., & McGee, J.O'D. (1995). Human papillomavirus status in the prediction of high -grade cervical intraepithelial neoplasia in patients with persistent low-grade cervical cytological abnormalities. British Journal of Cancer, 71, 206-209.
46. Hildesheim,A., Schiffman, M.H., Gravitt, P.E., Glass, A.G., Greer, C.E., Zhang, T., Scott, D.R., Rush, B.B., Lawler, P., Sherman, M.E., Kurman, R.J., & Manos, M.M. (1994). Persistence of type-specific human papillomavirus infection among cytologically normal women. Journal of Infectious Diseases, 169, 235-240.
47. Ho, G.Y, Burk, R.D., Klein, S., Kadish, A.S, Chang, C.J, Palan, P., Basu, J., Tachezy, R., Lewis, R., & Romney, S. (1995). Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. Journal of the National Cancer Institute, 87, 1365-1371.
48. International Agency for Research on Cancer Working Group on Evaluation of Cervical Cancer Screening Programs. (1986). Screening for squamous cervical cancer: Duration of low risk after negative results of cervical cytology and its implications for screening policies. Lancet, 293, 659-664.
49. Johnson, K. (1995). Periodic health exanimation 1995 update: 1. Screening for human papillomavirus infection in asymptomatic women. Canadian Medical Association Journal, 152, 483-493.
50. Jones, H., Noller, K., Reid, R., & Richart, R. (1994). Treating patients who have low-grade Pap smears. Contemporary Ob/Gyn, 39, 99-114.
51. Kataja, V. (1992). Genital human papillomavirus (HPV) infections. Prevalence, incidence, risk factors and prognosis. Kuopio University Publications Department of Medical Sciences, 13.
52. Kiviat, N.B., & Koutsky, L.A. (1993). Specific human papillomavirus types as causal agents of most cervical intraepithelial neoplasia: Implications for current views of treatment. Journal of the National Cancer Institute, 85, 934-935.
53. Koss, L.G. (1993). Cervical (Pap) smear. New directions. Cancer, 71, 1406-1412.
54. Koutsky, L.A., Holmes, K.K., Critchlow, C.W., Stevens, C.E., Paavonen, J., Beckmann, A.M., DeRouen, T.A., Galloway, D.A., Vernon, D., & Kiviat, N.B. (1992). A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection.New England Journal of Medicine, 327, 1272-1278.
55. Kurman, R.J. (1994). Blaustein's Pathology of the female genital tract (4th ed.). New York: Springer-Verlag.
56. Kurman, R.J., Henson, D.E., Herbst, A.L., Noller, K.L., & Schiffman, M.H. (1994). Interim guidelines for management of abnormal cervical cytology. Journal of the American Medical Association, 271, 1866-1869.
57. Lungu, O., Sun, X.W., Felix, J., Richart, R.M., Silverstein, S., & Wright, T.C. (1992). Relationship of human papillomavirus type to grade of cervical intraepithelial neoplasia.Journal of the American Medical Association, 267, 2493-2496.
58. Lytwyn, A., Sellors, J.W., & Gafni, A. (1995).Effectiveness and efficiency of a repeat smear vs immediate HPV-DNA testing and colposcopy in women with low grade Pap smears in family practice. (Grant No. 95-32). Toronto: Physicians' Services Incorporated Foundation.
59. Mahony, J.B., Luinstra, K.A., & Chong, S. (1995, August). Detection of human papillomavirus (HPV) in urine by polymerase chain reaction (PCR) as an alternative to testing cervical specimens. Paperpresented at the meeting of the Proceedings of the Eleventh Meeting of the International Society of Sexually Transmitted Disease Research, New Orleans, Louisiana.
60. Maiman, M. (1994). The Northfelt article revisited. Oncology, 8, 38-40.
61. Mayeaux, E.J., Harper, M.B., Barksdale, W., & Pope, J.B. (1995). Noncervical human papillomavirus genital infection. American Family Physician, 52, 1137-1146.
62. Maymon, R., Shulman, A., Maymon, B., Bekerman, A., Werchow, M., Faktor, J.H., & Altaras, M. (1994). Penile condylomata: A gynecological epidemic disease: A review of the current approach and management aspects. Obstetrical and Gynecological Survey, 49, 790-800.
63. McDougall, J.K., Galloway, D.A., & Daling, J.R. (1996). Human papillomavirus - biology, clinical significance and epidemiology. (Project No. 5 P01 CA42792-10 SUB 0001,004). Washington, DC: National Institutes of Health.
64. McNeil, C. (1997). Where the HPV vaccine trials are. Journal of the National Cancer Institute, 89, 281.
65. Mehal, W.Z., Lo, YM-D., Herrington, C.S., Evans, M.F., Papadopoulos, M.C., Odunsi, K., Ganesan, T.S., McGee, J.O'D., Bell, J.I., & Fleming, K.A. (1994). Role of human papillomavirus in determining the HLA associated risk of cervical carcinogenesis Journal of Clinical Pathology, 47, 1077-1087.
66. Miller, A.B., Anderson, G., Brisson, J., Laidlaw, J., Le Pitre, N., Malcolmson, P., Mirwaldt ,P., Stuart, G., & Sullivan, W. (1991). Report of a national workshop on screening for cancer of the cervix. Canadian Medical Association Journal, 145, 1301-1325.
67. Morrison, E.A.B., Goldberg, G.L., Hagan, R.J., Kadish, A.S., & Burk, R.D. (1992). Self-administered home cervicovaginal lavage: A novel tool for the clinical-epidemiologic investigation of genital human papillomavirus infections. American Journal of Obstetrics and Gynecology, 167, 104-107.
68. Moscicki, A.B. (1993). Comparison between methods for human papillomavirus DNA testing: A model for self-testing in young women. Journal of Infectious Diseases, 167, 723-725.
69. Moscicki, A.B., Palefsky, J., Smith, G., Siboshski, S., & Schoolnik, G. (1993). Variability of human papillomavirus DNA testing in a longitudinal cohort of young women.Obstetrics and Gynecology, 82, 578-585.
70. Naish, J., Brown, J., & Denton, B. (1994). Intercultural consultations: Investigation of factors that deter non-English speaking women from attending their general practitioners for cervical screening. British Medical Journal, 309, 1126-1128.
71. Northfelt, D.W. (1994). Cervical and anal neoplasia and HPV infection in persons with HIV infection. Oncology, 8, 33-37.
72. OMA Ad Hoc Committee on Cervical Cancer Screening. (1993). Cervical cancer screening in Ontario. Toronto: Ontario Medical Association.
73. Palefsky, J. (1991). Human papillomavirus infectionamong HIV- infected individuals.Hematology/Oncology Clinics of North America, 5, 357-370.
74. Palefsky, J. (1995). Serologic detection of human papillomavirus-related anogenital disease: New opportunities and challenges. Journal of the National Cancer Institute, 87, 4-5.
75. Palefsky, J.M. (1994). Anal human papillomavirus infection and anal cancer in HIV-positive individuals: An emerging problem. AIDS, 8, 283-295.
76. Palefsky, J.M., & Holly, E.A. (1995). Molecular virology and epidemiology of human papillomavirus and cervical cancer. Cancer Epidemiology Biomarkers and Prevention, 4, 415-428.
77. Parboosingh, E.J., Anderson, G., Clarke, E.A., Inhaber, S., Kaegi, E., Mills, C., Mao, Y., Root ,L., Stuart, G., & Stachenko, S. (1996). Cervical cancer screening: Are the 1989 recommendations still valid? Canadian Medical Association Journal, 154, 1847-1853.
78. Pou, A.M., Rimell, F.L., Jordan, J.A., Shoemaker, D.L., Johnson, J.T., Barua, P., Post, J.C., & Ehrlich, G.D. (1995). Adult respiratory papillomatosis: Human papillomavirus type and viral coinfections as predictors of prognosis. Annals of Otology Rhinology and Laryngology, 104, 758-761.
79. Rader, J.S. (1996). HLA, human papillomavirus and invasive cervical cancer. (Project No. 5 R03 CA62009-02). Washington, DC: National Institutes of Health.
80. Ramanujam, P.S., Venkatesh, K.S., Barnett, T.C., & Fietz, M.J. (1996). Study of human papillomavirus infection in patients with anal squamous carcinoma. Diseases of the Colon and Rectum, 39, 37-39.
81. Reid, R., & Lorincz, A. (1991). Should family physicians test for human papillomavirus infection? Journal of Family Practice, 32, 183-188.
82. Remmink, A.J., Walboomers, J.M.M., Helmerhorst, T.J.M., Voorhorst, F.J., Rozendaal, L., Risse, E.K.J., Meijer, C.J.L.M., & Kenemans, P. (1995). The presence of persistent high-risk HPV genotypes indysplastic cervical lesions is associated with progressive disease: Natural history up to 36 months.International Journal of Cancer, 61, 306-311.
83. Richart, R.M., & Wright, T.C. (1993). Controversies in the management of low-grade cervical intraepithelial neoplasia. Cancer, 71, 1413-1421.
84. Roman, A., & Fife, K. (1986). Human papillomavirus DNA associated with foreskins of normal newborns. Journal of Infectious Diseases, 153, 855-861.
85. Roy, M., Edwards, L., Ferenczy, A., Sedlacek, T.V., Fox, T.L., Smith, S.L., Gayoso, K.A., Owens, M.L., & Study Group. (1996, May). Efficacy of topical imiquimod for the treatment of genital/perianal warts. Paper presented at the meeting of the Ninth World Congress on Cervical Pathology and Colposcopy, Sydney, Australia.
86. Schiffman, M.H. (1993). Latest HPV findings: Some clinical implications. Contemporary Ob/Gyn, 38, 27-40.
87. Schiffman, M.H. (1995). New epidemiology of human papillomavirus infection and cervical neoplasia Journal of the National Cancer Institute, 87, 1345-1347.
88. Schiffman, M.H., Bauer, H.M., Hoover, R.N., Glass, A.G., Cadell, D.M., Rush, B.B., Scott, D.R., Sherman, M.E., Kurman, R.J., Wacholder, S., Stanton, C.K., & Manos, M.M. (1993). Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia.Journal of the National Cancer Institute, 85, 958-964.
89. Schneider, A. (1996). Virologic screening. European Journal of Obstetrics Gynecology and Reproductive Biology, 65, 61-63.
90. Schneider, A., Kirchhoff, T., Meinhardt ,G., & Gissmann, L. (1992). Repeated evaluation of human papillomavirus 16 status in cervical swabs of young women with a history of normal Papanicolaou smears. Obstetrics and Gynecology, 79, 683-688.
91. Sellors, J.W. (1995). Sexually transmitted diseases. In J. Gray (Ed.),Therapeutic Choices (pp. 636-650). Ottawa: Canadian Pharmaceutical Association.
92. Sellors, J.W., & Law, C. (1994). Anogenital human papillomavirus infection. Changes in understanding and management. Canadian Family Physician, 40, 93-101.
93. Sellors, J.W., Lorincz, A.T., Mahony, J.B., Mielzynska, I., Lytwyn, A., & Chernesky, M.A. (1997, March). Self-sampling for sexually transmitted human papillomavirus (HPV). Paper presented at the meeting of Eurogin 97, 3rd International Congress, Paris, France.
94. Sellors, J.W., Lytwyn, A., & Gafni, A. (1995). Primary care trial of triage based on HPV-DNA testing in women with low grade Pap smears (Grant No. Mt. 13287). Ottawa: Medical Research Council of Canada.
95. Sellors, J.W., Pickard, L., Gafni, A., Goldsmith, C.H., Jang, D., Mahony, J.B., & Chernesky, M.A. (1992). Effectiveness and efficiency of selective vs universal screening for chlamydial infection in sexually active young women Archives of Internal Medicine, 152, 1837-1844.
96. Sheets, E.E., & Crum, C.P. (1994). Current status and future clinical potential of human papillomaviras infection and intraepithelial neoplasia. Current Opinion in Obstetrics and Gynecology, 5, 63-66.
97. Sherris, J.D., Wells, E.S., Tsu, V.D., & Bishop, A. (1993). Cervical cancer in developing countries: A situation analysis. Washington, DC: The World Bank, Program for Appropriate Technology in Health.
98. Slawson, D.C., Bennett, J.H., & Herman, J.M. (1993). Follow-up Papanicolaou smear for cervical atypia: A re we missing significant disease? Journal of Family Practice, 36, 289-293.
99. Smits, H.K., Bollen, L.J.M., Tjong-A-Hung, S.P., Vonk, J., Van der Velden, J., Kate, F.J.W.T., Kaan, J.A., Mol, B.W., & Schegget, J. T. (1995). Intermethod variation in detection of human papillomavirus DNA in cervical smears.Journal of Clinical Microbiology, 33, 2631-2636.
100. Sokal, D.C., & Hermonat, P.L. (1995). Priorities forvaginal microbicide research. American Journal of Public Health, 85, 737-738.
101. Solomon, D. (1993). Screening for cervical cancer: prospects for the future.Journal of the National Cancer Institute, 85, 1018-1019.
102. Stoler, M.H. (1996). A brief synopsis of the role of human papillomaviruses in cervical carcinogenesis. American Journal of Obstetrics and Gynecology, 175, 1091-1098.
103. Stone, K.M. (1995). Human papillomavirus infection and genital warts: Update on epidemiology and treatment. Clinical Infectious Diseases, 20 (Suppl. 1), 91-97.
104. Syrjanen, K.J. (1995). Spontaneous evolution of intraepithelial lesions according to the grade and type of the implicated human papillomaviras (HPV). European Journal of Obstetrics and Gynecology and Reproductive Biology, 65, 45-53.
105. Van Den Brule, A.J., Walboomers, J.M., Du Maine, M., Kenemans, P., & Meijer, C.J. (1991). Difference in prevalence of human papillomavirus genotypes in cytomorphologically normal cervical smears is associated with a history of cervical intraepithelial neoplasia. International Journal of Cancer, 48, 404-408.
106. von Krogh, G., Gross, G., & Barrasso, R. (1997). Wart and HPV-related squamous cell tumors of the genitoanal area in adults. In Gerd Gross & Geo von Krough (Eds.), Human Papillomavirus Infections in Dermatovenereology (pp. 260-287). New York: CRC Press.
107. Vossler, J.L., Forbes, B.A., & Adelson, M.D. (1995). Evaluation of the polymerase chain reaction for the detection of human papillomavirus from urine. Journal of Medical Virology, 45, 354-360.
108. Wideroff, L., Schiffman, M.H., Nonnenmacher, B., Hubbert, N., Kirnbauer, R., Greer, C.E., Lowy, D., Lorincz, A.T., Manos, M.M., Glass, A.G., et al. (1995). Evaluation of seroreactivity to human papillomavirus HPV 16 virus-like particles in an incident case-control study of cervical neoplasia. Journal of Infectious Diseases, 172, 1425-1430.
109. Woodman, C.B.J., Rollason ,T., Ellis, J., Tierney, R., Wilson, S., & Young, L. (1996). Human papillomavirus infection and risk of progression of epithelial abnormalities of the cervix. British Journal of Cancer, 73,553-556.
110. Woolley, P. (1995). Identifying and treating genital warts. Practitioner, 239, 542-546.
111. Wright, T.C., Sun, X.W., & Koulos, J. (1995). Comparison of management algorithms for the evaluation of women with low-grade cytologic abnormalities. Obstetrics and Gynecology, 85, 202-210.
112. Zazove, P., Reed, B.D., Gregoire, L., Gorenflo, D.W., Lancaster, W.D., Ruffin, M.T., & Hruszczyk, J. (1993). Presence of human papillomavirus infection of the uterine cervix as determined by different detection methods in a low-risk community-based population. Archives of Family Medicine, 2, 1250-1258.